LivingGLP1
parallel randomized trial

S003110

Design

Randomized
24
Start year
Treatment
Countries
United States (1 sites)
Sponsor
(non industry)
Eligibility
severely burned children; no diabetes before the burn

Conduct and analysis

Blinding
open label
Sequence generation
not reported
Allocation concealment
not reported
Outcome adjudication
not reported
Primary estimand
not stated
Analysis population
randomized
Missing data

Arms

ArmTreatmentBackgroundRandomizedAnalyzedCompleted treatment
A1Intensive insulin
Intensive insulin treatment
total enteral nutrition; lifestyle: standard1818
A2exenatide
Exenatide plus insulin if needed
total enteral nutrition; lifestyle: standard66

Baseline characteristics

As printed in the trial reports or registry, per arm or for the whole trial.
CharacteristicStatisticIntensive insulin
A1
Exenatide plus insulin if needed
A2
agemean (years)1212
agesd (years)45
weightmean (kg)4149
weightsd (kg)1923

Results

6 adjudicated result lines, grouped by outcome. Open an outcome to see its values.
Discontinuation due to adverse events (2 lines; O26)
WeekArmStatisticEstimateSE or SD95% CIEvents / NDetail
A1events0 / 18not stated; randomized; R0027200:Figure 1
A2events0 / 6not stated; randomized; R0027200:Figure 1
Discontinuation due to gastrointestinal adverse events (2 lines; O27E)
WeekArmStatisticEstimateSE or SD95% CIEvents / NDetail
A1events0 / 18not stated; randomized; R0027200:Figure 1
A2events0 / 6not stated; randomized; R0027200:Figure 1
Death by suicide (2 lines; O35B)
WeekArmStatisticEstimateSE or SD95% CIEvents / NDetail
A1events0 / 18not stated; safety; R0027200:Results
A2events0 / 6not stated; safety; R0027200:Results